Change Tools, Not Workflow

Diabetes Testing Centers™ offers a wide range of assessments and therapies, all of which are eligible for CMS reimbursements across the country. Primary Care providers can use our services to identify and measure the severity of a disease and make better referrals to specialist with patients who may have a greater need to be seen. Many independent medical clinics use and rely on outdated and subjective tools. This may be due to cost and workflow considerations but given the challenges faced by primary care providers so it is essential to use point-of-care tests that do not take additional workflow and can be performed by a medical assistant to assist in disease diagnosis.

Our point-of-care and non-invasive assessments are designed to provide you with quick, yet comprehensive results in just 3-5 minutes. By utilizing our cutting-edge tools, you can offer your patients the education, support, and resources they need to improve their quality of life, especially when it comes to diabetes. With our bundles or à la carte options, you can select the perfect test or therapy that meets your clinic's unique requirements and helps your diabetic patients achieve optimal health outcomes. 

We offer complete program management or simply offer purchasing, renting, and leasing options. Discover Diabetes Testing Centers™ possibilities. Below is a financial pro form for our DTC MAX (ANS+DPN+DRE+PAD) with seven (7) billing codes for a turnkey bundle.

Diabetes Accounts for 66% of Office Visits for Primary Care and Grows to 76% when Diabetes is the Reason for a Visit.

J Gen Intern Med. 2019 Jul; 34(7): 1089–1091. 

Diabetic Neuropathy (Painful & Painless)

Pain affects people in the U.S. more than diabetes, heart disease, and cancer. The CDC has reported that failing to objectively diagnose painful and painless neuropathy can lead to amputations of the toes, feet, or legs. Primary care providers play a key role in caring for patients with chronic pain, but many clinicians and insurance companies fail to emphasize the value of nonopioid alternatives. Diabetic Neuropathy (DN) is often recognized in two forms of peripheral neuropathy due to diabetes mellitus, which are often in the same patient living with diabetes: 50% may be symptomatic or painful (small fiber), and up to 50% may be asymptomatic or insensate (large fiber). Pain is often at the top of the list of painful conditions, and asymptomatic neuropathy, also known as loss of protective sensation (LOPS), also has life-altering changes for patients since both have morbidity and mortality risks. 

(Painful) Small Fiber Neuropathy Can Only be Verified with Thermal Thresholds or Skin Biopsies.

Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018

The natural history of DN remains poorly understood, as few prospective studies have examined this condition. The main reason is the lack of standardized methodologies for the diagnosis of DN. Unlike diabetic retinopathy and nephropathy, the lack of simple, accurate, and readily reproducible methods of measuring neuropathy has been a major challenge. Furthermore, the methods currently used are not only subjective and reliant on the examiner’s interpretation but tend to diagnose DN when it’s already well established. Painful DN occurs in up to 34% of patients with diabetes and can pose a significant clinical management challenge when poorly managed. When patients fail a monofilament test, they may have severe neuropathy, and it may be too late to intervene. The appropriate diagnosis must be objectively assessed as early as possible to manage a patient's care or be referred to the appropriate specialists.

(Painless) Diabetic large nerve fiber dysfunction, as measured by vibration, predicts foot ulceration, amputation, and mortality.

https://care.diabetesjournals.org/content/32/10/1896